All News #Library
Biotech
FDA Fast-Track Designation TRIANA`s TRI-611 for ALK+ NSCLC Cancer
25 Mar 2026 //
PHARMIWEB
TRIANA Doses First Patient In TRI-611 Ph1/2 NSCLC Trial
19 Mar 2026 //
PHARMIWEB

Market Place
Sourcing Support